10x Genomics (TXG) Other financing activities (2019 - 2023)

10x Genomics has disclosed Other financing activities across 5 years of filings, most recently posting $5.8 million for Q1 2023.

• Other financing activities for Q1 2023 came in at $5.8 million, up 7.49% year-over-year; the trailing twelve-month figure through Dec 2023 was $5.8 million (up 7.49% YoY), and the FY2023 annual result was $5.8 million, up 7.49% from the prior year.
• Other financing activities came in at $5.8 million for Q1 2023 at 10x Genomics, up from $5.4 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $5.8 million in Q1 2020 to a low of -$1.9 million in Q3 2019.
• The 5-year median for Other financing activities is $5.0 million (2021), against an average of $3.2 million.
• Across the five-year window, Other financing activities slipped 13.99% in 2021 and increased 7.58% in 2022, its largest moves.
• 10x Genomics' Other financing activities stood at -$1.9 million in 2019, then surged by 100.1% to $2000.0 in 2020, then surged by 251300.0% to $5.0 million in 2021, then advanced by 7.58% to $5.4 million in 2022, then advanced by 7.49% to $5.8 million in 2023.
• The last three Other financing activities figures came in at $5.8 million (Q1 2023), $5.4 million (Q1 2022), and $5.0 million (Q1 2021), per Business Quant data.